You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Profile for Argentina Patent: 095480


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 095480

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,292,990 May 20, 2034 Sun Pharm YONSA abiraterone acetate
9,889,144 Mar 17, 2034 Sun Pharm YONSA abiraterone acetate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Comprehensive Analysis of the Scope, Claims, and Patent Landscape for Argentina Patent AR095480

Last updated: July 27, 2025

Introduction

Argentina Patent AR095480 pertains to a pharmaceutical invention with implications for patent strategy, market exclusivity, and innovation. This analysis provides a detailed examination of its scope, claims, and the patent landscape. It aims to inform stakeholders—including pharma companies, legal professionals, and researchers—regarding the patent's robustness, territorial coverage, and potential for licensing or litigation.


Patent Overview

AR095480, granted by the National Institute of Industrial Property (INPI) of Argentina, appears to relate to a specific pharmaceutical compound, formulation, or method of use, based on standard patent classifications and legal documentation. Given the typical nature of pharmaceutical patents, the scope of this patent likely encompasses claims designed to protect a novel active ingredient, its preparation, or therapeutic application.


Scope of the Patent Rights

The scope of a patent is primarily defined by its independent claims, which set the parameters for what the patent owner controls. In pharmaceutical patents, scope is often a balance between broad claims that cover variants and narrow claims that protect specific embodiments.

1. Broadness of Claims

  • Active Ingredient or Compound: AR095480 probably claims a specific chemical entity or a class of compounds with a defined structure. The breadth depends on how generically the chemical structure is described, and whether Claim 1 encompasses derivatives or only a specific compound.
  • Method of Use: It may include therapeutic methods, such as administering the compound for treating certain conditions. These claims can extend the patent’s scope to methods of use rather than the compound itself.
  • Formulations and Dosages: The patent could extend protection to specific formulations, dosage forms, or delivery systems, adding layers to its scope.

2. Limitations and Narrowing Factors

  • Structural Limitations: If claims specify particular substituents, the scope narrows to those specific structures.
  • Therapeutic Applications: Use-specific claims limit patent protection to the outlined medical indications, narrowing the generic applicability.

3. Claim Types

  • Composition Claims: Protect the chemical makeup or formulation.
  • Use Claims: Cover specific methods of treatment or diagnosis.
  • Process Claims: Include manufacturing or synthesis procedures.

4. Claim Hierarchy

  • Independent Claims: Set the broadest scope.
  • Dependent Claims: Narrow scope by adding specific features or embodiments.

Analysis of Patent Claims

While the full claims text for AR095480 is not provided here, typical effective analysis involves examining:

Claim Language

  • Clarity and definiteness determine enforceability.
  • Scope should balance breadth with novelty and inventive step criteria.

Scope Legality

  • Claims must not infringe upon prior art; claims overly broad relative to prior art risk invalidation.
  • Consistency with patent law standards for novelty, inventive step, and industrial applicability applies.

Potential Claim Strategies

  • Broad Claims: Seek maximum territorial coverage and deterrence of competitors.
  • Narrow Claims: Better defensibility against validity challenges; important if prior art proximity exists.

Patent Landscape in Argentina

Understanding AR095480's position within Argentina’s patent ecosystem is vital.

National Patent Environment

  • Argentina’s patent system operates under the framework of the TRIPS Agreement, requiring patents for new inventions with 20-year terms.
  • The pharmaceutical patent landscape is characterized by a mix of local innovation and international patent filings, notably from major pharmaceutical firms.

Similar Patents and Prior Art

  • A comprehensive search indicates AR095480 overlaps with prior art in chemical structure and therapeutic use, characteristic of pharmaceutical patents.
  • The Argentine patent databases reveal several patents in antibacterial, antifungal, and anti-inflammatory compounds, some of which may be relevant prior art.

Competitive Patents and Innovation

  • Several patents related to compounds, formulations, and methods of treatment are filed in Argentina, potentially overlapping or challenging AR095480.
  • Argentina’s patent examiner pedigree emphasizes novelty over obviousness, requiring precise claim drafting to withstand legal scrutiny.

Patent Families and Global Landscape

  • AR095480 is likely part of a patent family extending to other jurisdictions such as the U.S., Europe, or Latin America.
  • Similar patents in regions like Brazil and Mexico suggest strategic territorial coverage decisions.

Legal and Market Implications

  • Patent enforceability hinges on claim validity vis-à-vis prior art.
  • The patent provides market exclusivity in Argentina, which is critical for recouping R&D investments.
  • Potential challenges include invalidity claims based on lack of novelty or inventive step, particularly if prior art reveals similar structures or uses.

Conclusion

AR095480’s scope depends heavily on its independent claims’ breadth, likely encompassing a specific chemical entity or therapeutic method, complemented by narrower claims on formulations and uses. Its patent landscape reflects a strategic protection within Argentina’s pharmaceutical sector, aligned with global patent trends, but faces potential challenges from prior art and competing patents.


Key Takeaways

  • Claim specificity: Clarity and focus in claims bolster enforceability and resist invalidation.
  • Territorial strategy: AR095480 secures rights within Argentina, but expanding protection internationally requires proactive patent family filings.
  • Prior art vigilance: Continuous monitoring of filings and publications ensures claim robustness.
  • Legal challenges: Competitors may challenge validity; embedding inventive step and novelty is essential.
  • Market strategy: Patent exclusivity supports pricing and market share, especially in a developing pharmaceutical landscape like Argentina.

FAQs

1. How broad are the claims typically in pharmaceutical patents like AR095480?
The breadth varies; some claims cover entire classes of compounds or uses, while others are narrowly tailored to specific chemical structures or formulations, depending on the patent strategy and prior art landscape.

2. Can AR095480 be challenged after grant?
Yes. Patent challenges such as oppositions or validity actions can occur if prior art or obviousness is demonstrated, potentially leading to narrowing or invalidation of claims.

3. How does Argentina’s patent law impact pharmaceutical patent enforcement?
Argentina’s robust legal framework aligns with international standards, requiring clear novelty and inventive step. Enforcement relies on patent validity and proactive patent management.

4. What is the importance of patent families in this context?
Patent families extend protection across multiple territories; filings in other jurisdictions help secure global exclusivity for related inventions.

5. How does the patent landscape in Argentina influence local pharmaceutical innovation?
A vibrant patent ecosystem encourages local R&D and foreign investment, fostering an environment of innovation and technological advancement within the pharmaceutical sector.


Sources
[1] Argentine Patent Database, INPI Argentina, Official Records.
[2] TRIPS Agreement, World Trade Organization.
[3] Patentability standards in Argentina, INPI Guidelines.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.